Panel Discussion with Regulators and Closing Remarks

Speaker(s):

• Wilson W. Bryan, M.D., Director, Office of Tissues and Advanced Therapies, CBER/FDA
• Matthew J. Davis, Senior GMP Inspector, Therapeutic Goods Administration
• Alyce Maksoud, Team Leader Inspection Section, PIC/S Chair, Tissue & Cells , Australian Government Department of Health (TGA)
• René Thürmer, Quality Assessor, BfArm
• Thomas B. Hartman, President and CEO, ISPE